Class II Drug Recalls
The 20 most recently initiated drug recalls from FDA enforcement reports, limited to Class II - Potentially Harmful recalls. Class I means a reasonable probability of serious harm or death, Class II a temporary or reversible health risk, and Class III a product unlikely to cause harm. Dates are recall initiation dates.
Lack of Assurance of Sterility
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare companyLack of Assurance of Sterility
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare companyLack of Assurance of Sterility
PfizerLabeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/
OurPharma LLCFailed Dissolution Specifications
Inventia Healthcare LimitedFailed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stab
SUN PHARMA /TARODefective Delivery System: Possibility of no medication in the prefilled pen.
Amneal Pharmaceuticals of New York, LLCFailed Dissolution Specifications
Mylan Pharmaceuticals IncFailed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
Hikma Pharmaceuticals USA INC.Presence of Foreign Tablets/Capsules
Teva Pharmaceuticals USA, IncCGMP Deviations: Potential contamination of raw material
Lexia LLCCGMP Deviations: Potential contamination of raw material
Lexia LLCFailed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissoluti
Golden State Medical Supply Inc.Lack of Assurance of Sterility
Sterling Pharmaceutical Services LLCLack of Assurance of Sterility
Sterling Pharmaceutical Services LLCLack of Assurance of Sterility
Sterling Pharmaceutical Services LLCLack of Assurance of Sterility
Sterling Pharmaceutical Services LLCLack of Assurance of Sterility
Sterling Pharmaceutical Services LLCLack of Assurance of Sterility
Sterling Pharmaceutical Services LLCLack of Assurance of Sterility
Sterling Pharmaceutical Services LLC